← Eichor
Condition: Influenza Human Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Influenza Human

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06907667Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06160128A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT07633288A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcino
EARLY_Phase 1 · 2 location(s) · Dana-Farber Cancer Institute · NCT06664151Clinical Trials of Quadrivalent Influenza Vaccine
Phase 1/Phase 2 · 1 location(s) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · NCT06824519Immune Defense Protein Impact On Respiratory Immune Outcomes
NA · 1 location(s) · Quantec Ltd · NCT07431840Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting
Phase 3 · 2 location(s) · Capital Medical University · NCT07236814First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07169318Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Phase 1/Phase 2 · 7 location(s) · Aramis Biotechnologies Inc. · NCT07291635Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04772170Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829INfluenza VaccInation To Mitigate typE 1 Diabetes
Phase 4 · 10 location(s) · Aarhus University Hospital · NCT05585983Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Pre
NA · 1 location(s) · Center for Primary Care and Public Health (Unisante), Univer · NCT07396428Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · 3 location(s) · PEACHES BIOTECH · NCT06684379Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04712539Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Sym
Phase 3 · 15 location(s) · Brainfarma Industria Química e Farmacêutica S/A · NCT07626437Systems Investigation of Vaccine Responses in Aging and Frailty
Phase 2 · 1 location(s) · Yale University · NCT05291676Influenza Immunization in Adults Over Age 75
NA · 1 location(s) · Johns Hopkins University · NCT02200276Influenza Vaccine Effectiveness in Among Young Children in Taiwan
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06446232Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza
Phase 3 · 2 location(s) · Instituto de Investigación Sanitaria y Biomédica de Alicante · NCT06528444Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adult
Phase 1/Phase 2 · 5 location(s) · Butantan Institute · NCT06842173A Study to Learn About mRNA Vaccines Against Influenza in Adults
Phase 2 · 15 location(s) · Pfizer · NCT07431853Response to Influenza Vaccination in Pediatric Oncology Patients
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT05384288COVID-19 Coagulopathy Extension Study
Phase N/A · 1 location(s) · University of Iowa · NCT05334615Influenza Vaccination After Acute Coronary Syndrome
NA · 1 location(s) · Tongji Hospital · NCT07259252Influenza Human Challenge Model
Phase 1 · 2 location(s) · Emory University · NCT05332899Intradermal Influenza Vaccination
EARLY_Phase 1 · 1 location(s) · Yale University · NCT06067555Immune Responses in Health Care Personnel
Phase N/A · 1 location(s) · Finnish Institute for Health and Welfare · NCT03323112
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.